MVR Blade for Micro Vitreo Retinal Stab Incision
Original price was: $60.00.$20.00Current price is: $20.00.
The MVR Blade ensures delicate precision and safety in vitreo-retinal microsurgery, making it indispensable for ophthalmic surgeons.
Description:
MVR Blade for Micro Vitreo Retinal Stab Incision The MVR Blade is designed specifically for microsurgical procedures in vitreo-retinal surgeries. It allows surgeons to create clean and precise stab incisions in the sclera and retina, minimizing trauma while ensuring optimal access for intraocular instruments. Its sharp, fine-pointed edge reduces resistance, resulting in controlled entry for retinal and vitreous interventions.
Key Features:
-
Ultra-fine, razor-sharp blade for smooth scleral and retinal entry.
-
Designed for stab incisions in micro vitreo-retinal procedures.
-
Provides clean wound margins to promote faster healing.
-
Available in standardized microsurgical sizes.
Shipping Policy
At SurgiPortal, we ensure fast, reliable, and secure shipping of surgical instruments worldwide.
Order Processing
All orders are processed within 5–8 working days, with multiple delivery options to suit your needs:
- Standard Shipping: 7–10 business days
- Express Shipping: 4–6 business days
- Priority Delivery: 2–4 business days (available in select regions)
Delivery Partners
We collaborate with trusted global carriers such as DHL, FedEx, and UPS. Additional options include registered airmail and bulk freight solutions for clinics and hospitals.
Packing Standards
Each order is carefully packed using sterile, damage-resistant materials to maintain the highest hygiene and safety standards during transit.
Order Tracking
Upon shipment, customers receive a tracking number to monitor their order in real-time.
Reliable Delivery
Our certified delivery network ensures timely arrival of your surgical supplies in excellent condition.
With SurgiPortal’s professional medical logistics, you can count on efficient delivery and superior service—every step of the way.
Reviews
There are no reviews yet.